Gaviscon antacid and reflux relief

Gaviscon is a globally recognized heart-burn and acid reflux treatment developed in the mid-20th century. Originally formulated in the United Kingdom, it has grown from a specialized pharmaceutical into a household staple for digestive health. The product works by forming a protective layer (raft) on top of the stomach contents to prevent acid from rising into the esophagus.

Today, the brand's manufacturing is decentralized, with major production facilities located in the United Kingdom (specifically Hull), as well as local manufacturing sites in various regions including Europe and Asia to meet local demand. Ownership transitioned through various pharmaceutical mergers, eventually landing with the British multinational Reckitt Benckiser (now simply Reckitt) in 2006 following the acquisition of Boots Healthcare International.